Skip to content
(480) 999-0905
FacebookLinkedin
Arizona's Only Accredited Master Surgeon - Greg J. Marchand M.D.Arizona's Only Accredited Master Surgeon - Greg J. Marchand M.D.
Arizona's Only Accredited Master Surgeon – Greg J. Marchand M.D.
Arizona's Only Accredited Master Surgeon – Greg J. Marchand M.D.
  • Dr. Greg Marchand
    • About Dr. Marchand
    • Funding & Independence
  • Fellowship
  • Research
    • Publications
    • Research Methodology
    • Clinical Trials
    • Research Team
  • Newsroom
    • Press Kit
    • Expert Commentary
    • Media Coverage
    • Video Appearances
  • Collaborate
  • Contact
  • Dr. Greg Marchand
    • About Dr. Marchand
    • Funding & Independence
  • Fellowship
  • Research
    • Publications
    • Research Methodology
    • Clinical Trials
    • Research Team
  • Newsroom
    • Press Kit
    • Expert Commentary
    • Media Coverage
    • Video Appearances
  • Collaborate
  • Contact

Now Online in BMJ Paediatrics Open: Our 79-Study Meta-Analysis on Prenatal Cannabis, Tobacco and Newborn Outcomes

November 15, 2026Minimally Invasive Surgery, OBGYNBy Maria Sainz
Now in BMJ Paediatrics Open: cannabis in pregnancy, tobacco explains much of the risk but not all. A systematic review and meta-analysis of 79 studies by Katelyn Sainz, MD, Greg J. Marchand, MD, and the Marchand Institute research team.

Our newest paper is online in BMJ Paediatrics Open, and it is open access, so anyone can read the whole thing. It goes back to a question my team first took on in 2022, this time with about five times the evidence and a much harder look at the one problem that has always dogged this literature: tobacco.

Prenatal cannabis exposure and adverse neonatal outcomes: a systematic review and meta-analysis with meta-regression on tobacco co-use

Sainz K, Gonzalez Herrera D, Robinson M, Kline E, Mera S, Koshaba M, O’Connell B, Ibrahim F, Marchand GJ. BMJ Paediatr Open. 2026;10(1):e004876. Published online November 13, 2026. DOI 10.1136/bmjpo-2026-004876.

Where to read it

The full article on bmjpaedsopen.bmj.com (open access, free to read) · DOI 10.1136/bmjpo-2026-004876. PubMed: PMID 43034090.

Why this paper matters to me

Our 2022 meta-analysis in JAMA Network Open pooled 16 studies of babies exposed to marijuana in utero, and it has become the most cited paper I have written. It also pooled crude numbers, with no adjustment for tobacco, and that is the first thing any careful reader asks about. Most women who use cannabis in pregnancy also smoke, and smoking on its own is one of the strongest causes of small babies and perinatal death. If we wanted to say anything useful about cannabis, we had to deal with tobacco head on.

Dr. Katelyn Sainz, a neonatology fellow at Dartmouth Hitchcock, led this one, and she sees these babies in the NICU. I am an OB-GYN surgeon who does a lot of epidemiology, which turns out to be a useful pairing for a question like this. The research team at the Institute did the heavy lifting on screening and extraction across nearly ten thousand records.

Explainer: why tobacco clouds the picture. Cannabis and tobacco travel together in pregnancy, most studies record tobacco as a single yes-or-no answer, how this review tested the smoking gap between groups, and why that matters.

What we did

We searched eight databases through September 20, 2026, with no language restriction, and ended up with 79 studies that contribute data, covering about 18.2 million pregnancies and roughly 180,000 exposed to cannabis. That is more studies than any previous review of this question. Every record was screened by two people independently, with a third settling disagreements, and the review was registered with PROSPERO before we started (CRD420251065325).

The new part is how we handled tobacco. Earlier reviews regressed on how much the cannabis group smoked. That cannot detect confounding: if both groups smoke heavily, there is nothing to confound. What matters is the difference in smoking between the two groups, so that is what we regressed on, and we refused to pool any estimate that had already had tobacco adjusted out, because an estimate like that cannot test anything. We also pooled the studies whose groups smoked about equally on their own, and compared every study that reported both an adjusted and an unadjusted estimate.

Prenatal cannabis and newborn outcomes by the numbers: 79 studies and about 18.2 million pregnancies, risk ratios of 1.90 for small for gestational age and 1.72 for low birth weight, 166 g lower birth weight, an 11 to 16 percent rise in the risk ratio for every 10-point widening of the smoking gap, 1.35 and 1.38 where tobacco was balanced, and very low certainty of evidence.

What we found

  • Cannabis exposure was associated with every outcome we looked at: small for gestational age (risk ratio 1.90), low birth weight (1.72), perinatal mortality (1.76), preterm birth (1.41), NICU admission (1.41) and a birth weight 166 g lower on average.
  • The bigger the smoking gap between the groups, the bigger the association. Each 10-point widening raised the risk ratio by 11% to 16% for low birth weight, small for gestational age, preterm birth and NICU admission, and the gap explained a third to three fifths of the variation between studies.
  • Where the groups smoked about equally, preterm birth and NICU admission were no longer significant. Small for gestational age (1.35) and low birth weight (1.38) were still raised, and both held up in the 39 studies that confirmed exposure with a lab test.
  • Perinatal mortality showed no tobacco gradient at all, so tobacco does not explain it. Only three balanced studies reported it, though, which is too few to confirm.
  • Within studies, adjustment that included tobacco removed a median of about half the association, anywhere from strengthening it to wiping it out. That is a big part of why we rate the certainty of this evidence very low, where the most recent review rated it moderate.

What it means

If you are pregnant: the advice is the same as it was. Avoid cannabis. If you also smoke, stopping both is the goal, and this paper is one more reason the two belong in the same conversation. If you counsel pregnant patients: bring up tobacco in the same breath, and lead with fetal growth, because that is the effect that survives the tobacco question. If you do meta-analysis in this field: pool estimates that have not already been adjusted for the confounder you are testing, use the difference between groups rather than prevalence in the exposed group, and report the tobacco-balanced studies on their own.

Quote from Greg J. Marchand, MD: Telling a pregnant patient to stop cannabis is good advice. Telling her to stop cannabis and saying nothing about the cigarettes misses much of the risk. Counsel both, and lead with fetal growth.

Thanks

Congratulations to Dr. Katelyn Sainz for leading this one, and thanks to Daniela Gonzalez Herrera, McKenna Robinson, Emily Kline, Sarah Mera, Michelle Koshaba, Brooklynn O’Connell and Fatma Ibrahim for the screening, extraction and assessment behind a review of this size.

Greg J. Marchand, MD, FACS, FACOG, FICS

Share this:

  • Share on X (Opens in new window) X
  • Share on Facebook (Opens in new window) Facebook

Like this:

Like Loading…

Related

Related posts
Now in the International Urogynecology Journal: once a midurethral sling is revised, further surgery is common. A litigation-derived case series of 252 women.
Now Online in the International Urogynecology Journal: Our Case Series of 252 Women With Midurethral Sling Complications
November 3, 2026
The Gray Journal: Our Cerclage Meta-Analysis Is Now Online in the American Journal of Obstetrics and Gynecology
November 1, 2026
New in EJOG: Surgical Management of Interstitial (Cornual) Pregnancy
October 10, 2026
American Journal of Obstetrics & Gynecology MFM (AJOG MFM) journal cover
Fresh Off the Press in AJOG MFM: Marchand Institute’s New Meta-Analysis on Single- vs. Double-Layer Uterine Closure and Cesarean Scar Outcomes
July 28, 2026
New Research from Dr. Greg Marchand: Evaluating the Impact of Robotic Assistance in Single-Site Hysterectomy
February 20, 2026
Exciting News: Dr. Marchand’s Latest Meta-Analysis on Opportunistic Salpingectomy for Epithelial Ovarian Cancer Prevention is Published and Open Access!
February 5, 2026
Articles
  • Now in BMJ Paediatrics Open: cannabis in pregnancy, tobacco explains much of the risk but not all. A systematic review and meta-analysis of 79 studies by Katelyn Sainz, MD, Greg J. Marchand, MD, and the Marchand Institute research team.
    Now Online in BMJ Paediatrics Open: Our 79-Study Meta-Analysis on Prenatal Cannabis, Tobacco and Newborn Outcomes
    November 15, 2026
  • Now in the International Urogynecology Journal: once a midurethral sling is revised, further surgery is common. A litigation-derived case series of 252 women.
    Now Online in the International Urogynecology Journal: Our Case Series of 252 Women With Midurethral Sling Complications
    November 3, 2026
  • The Gray Journal: Our Cerclage Meta-Analysis Is Now Online in the American Journal of Obstetrics and Gynecology
    November 1, 2026
  • New in EJOG: Surgical Management of Interstitial (Cornual) Pregnancy
    October 10, 2026
  • American Journal of Obstetrics & Gynecology MFM (AJOG MFM) journal cover
    Fresh Off the Press in AJOG MFM: Marchand Institute’s New Meta-Analysis on Single- vs. Double-Layer Uterine Closure and Cesarean Scar Outcomes
    July 28, 2026
  • New Research from Dr. Greg Marchand: Evaluating the Impact of Robotic Assistance in Single-Site Hysterectomy
    February 20, 2026
What patients say
  • 14517468_1646198135690553_6990924301147850409_n“I delivered both my beautiful babies with Dr. Marchand and I wouldn’t have it any other way! Every doctor visit up until I was in labor was great, he took all the time to answer all my questions. I didn’t feel rushed in and rushed out of the office. The office was always very clean! The staff were always very friendly. When I was in labor he made sure my birth plan was the most important thing! He always had my best interest in hand! My first delivery I was induced and it took 3 long days and Marchand kept checking on me all hours of the night!! If I did it all over again I’d definitely use Marchand as my OB again!”

    Related

    Alex S.
  • “We congratulate Dr. Greg J. Marchand as SRC’s first Surgeon of Excellence in Minimally Invasive Surgery (SOEMIS) in the United States. To achieve SOEMIS accreditation, Dr. Marchand invited SRC to complete a rigorous onsite inspection and thorough chart review to illustrate his compliance with the program. Dr. Marchand and his practice exemplify SRC’s commitment to patient safety and care.”

    Related

    Ashley DuBray, Senior Director of the Surgical Review Corporation
  • “I initially met Dr. Marchand upon an emergency room visit due to complications during my first pregnancy. My husband and I had recently moved from out of state. Not knowing many people here, in a scary situation and finding myself hospitalized was made a lot easier once we met Dr. Marchand who we decided would be the best doctor to see my care through the pregnancy and ultimate c-section. He always had time for our questions even when we knew he had many other patients. He did a great job with the surgery and follow up care and was very pleasant, patient and professional throughout the process. When we decided to have another baby, he saw us through another pregnancy and c-section and continues to be my OB of choice. I would recommend him in a heartbeat to any girlfriends I know.”

    Related

    Megan E. of Gilbert, AZ
  • “Growing up I have had my fair share of woman health issue from Endometriosis, PCOS, Severe Pelvic Pain, Loss of Pregnancy and Infertility and more pelvic surgeries than I can count. I have seen many different doctors till about 6-7 years ago when I needed emergency surgery and met Dr. Marchand and now I refuse to go to any one else. With the many issues I have had both Dr. Marchand as well as his whole office staff have been so helpful I couldn’t be more grateful. It’s very hard to find an honest, trustworthy doctor these days but rest assured you can’t go wrong with Dr. Greg Marchand. They are open late and almost always can fit you into the schedule for emergencies and you can always reach him no matter what time it is if you have questions. Dr. Marchand is an amazing surgeon and loves what he does. He has delivered many friends and family’s children and hope that one day he will be able to deliver mine as well.”

    Related

    Tomi M. of Gilbert
Arizona's Only Accredited Master Surgeon - Greg J. Marchand M.D.
© Greg Marchand MD

Loading Comments...
%d

    Research repository

    Every paper, abstract and presentation Dr. Marchand publishes is listed in his open research repository. Subscribe by RSS to be notified whenever new work is added.

    Browse the repository All research (RSS)

    Topic feeds: Peer-reviewed articles | Conference presentations